Notice of Correction to Cover Instructions for RFA-DK-17-024 Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)

Notice Number: NOT-DK-18-014

Key Dates
Release Date: April 20, 2018

Related Announcements
RFA-DK-17-024

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to correct language in Section IV.2 Application and Submission Information, Content and Form of Application Submission, SF424(R&R) Cover to remove the additional instructions related to Estimated Project Funding.  The appropriate Modular or R&R Budget form must be uploaded.
 

Current Language:

SF424(R&R) Cover 

All instructions in the SF424 (R&R) Application Guide must be followed.

Estimated Project Funding: Enter the budget request on the face page only. This number should include total costs (direct and indirect) for the entire project period. Note that a detailed budget cannot be accepted in the application; it will be requested as part of the Just-in-Time information. 

The Estimated Project Funding language does not apply to this FOA and has been deleted, the language has been modified as follows:


Revised Language:

SF424(R&R) Cover

All instructions in the SF424 (R&R) Application Guide must be followed.
Estimated Project Funding: All instructions in the SF424 (R&R) Application Guide must be followed. There are no additional instructions for Estimated Project Funding specific to this FOA. 


All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Guillermo Arreaza-Rubin, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4724
Email: arreazag@mail.nih.gov